Top Markets
Coin of the day
Spago Nanomedical AB (publ) Spago Nanomedical AB (publ)

Spago Nanomedical AB (publ)

SPAGO
Rang in aandelen #32285
Operating primarily in Sweden, Spago Nanomedical AB (publ) is dedicated to... Operating primarily in Sweden, Spago Nanomedical AB (publ) is dedicated to pioneering nanomedicines for both the diagnosis and treatment of cancer. The company is actively pursuing two key projects: the SpagoPix initiative, centered on SN132D, a gadolinium-free MRI contrast agent developed for imaging breast and pancreatic cancers; and the Tumorad project, which is advancing SN201, a radionuclide therapy intended for managing advanced and metastatic forms of cancer. Originally established as Spago Imaging AB (publ), the company adopted its current name, Spago Nanomedical AB (publ), in May 2014. Founded in 1999, its base of operations is situated in Lund, Sweden.
Aandeelprijs
$0.01317984
Laatst gesynchroniseerd: 2026-08-17
Marktkapitalisatie
$10.52M
Verandering (1 dag)
-1.26%
Verandering (1 jaar)
-53.51%
Land
SE
Handel Spago Nanomedical AB (publ) (SPAGO)

Categorie

Koersgeschiedenis voor Spago Nanomedical AB (publ) (SPAGO)
Hoogste slotkoers: $0.01 op 2026-08-01

Laagste slotkoers: $1.82 op 2013-01-01
Koersgeschiedenis van Spago Nanomedical AB (publ) van 2013 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) 49.55%
2025 -31.97%
2024 -41.92%
2023 -54.33%
2022 -87.66%
2021 -49.08%
2020 -37.41%
2019 30.59%
2018 14.03%
2017 -24.70%
2016 -12.65%
2015 29.84%
2014 -30.41%
2013 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$515.58 32.24%
US
$992.01 50.00%
NL
$111.17 -36.90%
AU
$736.64 6.99%
CH
$1.06K -6.61%
KR